Editas Medicine, Inc. has grown revenue 35% a year over three years and −10% a year over five. Revenue growth, 3-year annual rate: +35% (Biotechnology median +17%). Revenue growth, 5-year rate: −10%, growth has picked up over the last three years. Years of annual history on file: 12, FY2014 to FY2025, as filed.

EDITEditas Medicine, Inc.

Healthcare

$2.83-28% 1Y

$2.83

$1.6652 weeks$4.15

Is it growing?

Good

Growing: revenue growing +21% year on year and operating margin widening (+27370.3 points).

2 good, 1 without data

Revenue trend+21% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −10% a year.

Margin direction+27370.3 points operating

Trailing-twelve-month operating margin, -349.0% now against -27719.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is EDIT growing?

Editas Medicine, Inc. has grown revenue 35% a year over three years and −10% a year over five.

+35%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −10%
Revenue growth, 5-year rate · +35% over three · growth has picked up over the last three years
Years of annual history on file: 12
Years of annual history on file · FY2014 to FY2025, as filed

Details›